AADI BIOSCIENCE INC's ticker is and the CUSIP is 00032Q104. A total of 77 filers reported holding AADI BIOSCIENCE INC in Q4 2022. The put-call ratio across all filers is 0.00 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,456,277 | 0.0% | 509,572 | 0.0% | 0.71% | +58.5% |
| Q2 2023 | $6,456,277 | 0.0% | 509,572 | 0.0% | 0.45% | -0.4% |
| Q1 2023 | $6,456,277 | +98650.0% | 509,572 | 0.0% | 0.45% | -40.5% |
| Q4 2022 | $6,538 | -99.9% | 509,572 | 0.0% | 0.75% | -5.3% |
| Q3 2022 | $7,200,000 | +14.7% | 509,572 | 0.0% | 0.80% | +26.2% |
| Q2 2022 | $6,278,000 | -52.1% | 509,572 | -34.0% | 0.63% | -30.2% |
| Q1 2022 | $13,108,000 | -58.4% | 772,416 | -40.7% | 0.90% | -52.4% |
| Q4 2021 | $31,477,000 | -24.9% | 1,303,390 | -8.7% | 1.90% | +0.9% |
| Q3 2021 | $41,917,000 | – | 1,427,213 | – | 1.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 26,666 | $193,062 | 17.76% |
| Alerce Investment Management, L.P. | 1,630,830 | $11,807,209 | 15.60% |
| ACUTA CAPITAL PARTNERS, LLC | 1,849,402 | $13,389,670 | 9.86% |
| Decheng Capital Management III (Cayman), LLC | 526,329 | $3,810,622 | 1.54% |
| Knott David M Jr | 183,688 | $1,330 | 0.52% |
| Vivo Capital, LLC | 509,572 | $6,456,277 | 0.45% |
| Ghost Tree Capital, LLC | 150,000 | $1,086,000 | 0.32% |
| Avoro Capital Advisors LLC | 2,849,402 | $20,629,670 | 0.31% |
| Parkman Healthcare Partners LLC | 75,961 | $549,958 | 0.12% |
| RA Capital Management | 590,218 | $4,273,178 | 0.10% |